Anti Estrogen Steroids Lentaron Formestane Powder For Breast Cancer , CAS 566-48-3

CAS 566-48-3 Anti Estrogen Steroids Formestane Lentaron For Breast Cancer

Abstract

Lentaron is a type I, steroidal aromatase inhibitor. It is used in the treatment of estrogen-receptor positive breast cancer in post-menopausal women. It is available as an intramuscular depot injection.

Lentaron is often used to suppress estrogen production from anabolic steroids or prohormones. It also acts as a prohormone to 4-hydroxytestosterone, an active steroid which displays weak androgenic activity in addition to acting as a mild aromatase inhibitor.

Lentaron has poor oral bioavailability and as such is no longer popular as many orally active aromatase inhibitors have been identified.

Indications/Purpose

Aromatase converts androstenedione to estrone, and also converts testosterone to estradiol. Lentaron is often used to suppressestrogen production during anabolic steroids and prohormone cycles. Due largely to Lentarons similarity to androstenedione, it also acts as a prohormone to 4-hydroxytestosterone , an active steroid which displays weak androgenic activity in addition to serving as a mild aromatase inhibitor.

Male bodybuilders and athletes also use it to prevent estrogenic side effects from anabolic steroids, to improve fat loss, and to increase muscle definition while dieting. However, several conclusive studies have demonstrated Lentarons estrogen blocking inferiority when compared to third generation AIs like Arimidex and Femara so its far less popular.

Dosage

The most common version of it sold was in a topical gel form and it was dosed at 100-200mgs per application. Users would apply it onto clean, dry skin and rub in thoroughly; usually on the thighs or upper arms. It took 1 to 5 minutes to dry.

The injectable version for both breast cancer purposes and bodybuilders is 125mgs twice per week or 250mgs once per week.

Injectable Anabolic Steroids